Cargando…
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging
PURPOSE: Carbohydrate antigen (CA) 19-9 has been established as the main serum marker for patients with intrahepatic cholangiocarcinoma (ICC). The aim of this study was to compare the prognostic value of CA 19-9 changes versus response determined by imaging in patients with ICC undergoing chemothera...
Autores principales: | Hahn, Felix, Müller, Lukas, Jungmann, Florian, Mähringer-Kunz, Aline, Tanyildizi, Yasemin, Düber, Christoph, Galle, Peter R., Weinmann, Arndt, Kloeckner, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256028/ https://www.ncbi.nlm.nih.gov/pubmed/32232655 http://dx.doi.org/10.1007/s00432-020-03200-2 |
Ejemplares similares
-
Distant Metastases in Patients with Intrahepatic Cholangiocarcinoma: Does Location Matter? A Retrospective Analysis of 370 Patients
por: Hahn, Felix, et al.
Publicado: (2020) -
Risk Stratification in Advanced Biliary Tract Cancer: Validation of the A.L.A.N. Score
por: Müller, Lukas, et al.
Publicado: (2020) -
Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8(th) edition of the UICC/AJCC Cancer staging system
por: Hahn, Felix, et al.
Publicado: (2020) -
Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk Assessment
por: Müller, Lukas, et al.
Publicado: (2021) -
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance
por: Mähringer‐Kunz, Aline, et al.
Publicado: (2021)